Fri.Dec 01, 2023

article thumbnail

This week in drug discovery (27 Nov – 1 Dec) 

Drug Discovery World

News round-up for 27 November – 1 December by DDW Digital Content Editor Diana Spencer. The key drug discovery news this week focuses on experimental approaches to the treatment of some of the most challenging diseases, including a mathematical model that can simulate Alzheimer’s progression and using CRISPR gene editing to ‘shred’ tumours. The top stories: Potential disease-modifying therapy for Parkinson’s disease An experimental drug has shown potential as a disease-modifying therapy fo

Therapies 130
article thumbnail

Brucine D restrains colorectal cancer tumorigenesis and autophagy by downregulating circ_0068464

Chemical Biology and Drug Design

BD could restrain CRC growth through repressing the circ_0068464/miR-520h/ATG5 axis. Abstract Bruceine D (BD) from Brucea javanica (L) exerts an antitumor effect in several human cancers. At present, it has not been reported whether BD inhibits the malignancy of colorectal cancer (CRC) cells. Therefore, investigating the role and regulatory mechanisms of BD in CRC is the main thrust of this study.

RNA 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CatSci adds cGMP analytical development services

Drug Discovery World

UK-based CatSci have expanded their offering to now include cGMP analytical capabilities for both small molecule and oligonucleotides. The new cGMP analytical capability will be led by Dr Sam Whitmarsh and Duncan Thompson, CatSci’s Director of Analytical Science and Digital Transformation, and Head of Dagenham site respectively. Dr Nigel Richardson, CatSci’s Director of New Modalities, will lead the analytical development of oligonucleotides.

article thumbnail

Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology

Chemical Biology and Drug Design

With network pharmacology, we tried to clarify the crucial bioactive components and underlying mechanism of Prunella vulgaris L. (PVL) against hepatocellular carcinoma (HCC). We found that PVL targets multiple cancer-related pathways and downstream targets, and quercetin, as one of the crucial components of PVL, has tumor-suppressive activity on HCC cells, probably via modulating PI3K/AKT1 pathway.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

FDA approves first therapy for rare non-cancerous tumours

Drug Discovery World

SpringWorks Therapeutics’ Ogsiveo (nirogacestat) has become the first drug to be approved for desmoid tumours in the US, following the go-ahead from the US Food and Drug Administration (FDA). Desmoid tumours are non-cancerous but can be locally aggressive. Although surgical removal has historically been the treatment of choice, there is a high risk that the tumour will return or that other health challenges will occur after removal.

article thumbnail

Human behavior guided by fast changes in dopamine levels

Science Daily: Pharmacology News

A new study shows that dopamine release in the human brain plays a crucial role in encoding both reward and punishment prediction errors. This means that dopamine is involved in the process of learning from both positive and negative experiences, allowing the brain to adjust and adapt its behavior based on the outcomes of these experiences.

122
122

More Trending

article thumbnail

One of the largest magnetic storms in history quantified: Aurorae covered much of the night sky from the Tropics to the Polar Regions

Science Daily: Pharmacology News

An international multidisciplinary team consisting of solar physicists, geophysicists, and historians from nine countries analysed observations of an extreme solar-terrestrial storm reported in historical records from February 1872. Their findings confirm that a moderate sunspot group triggered one of the largest magnetic storms ever recorded, almost covering the entire night sky with colourful aurorae in both hemispheres.

article thumbnail

Identical Twins Study Shows Vegan Diets Helping the Heart

Drugs.com

FRIDAY, Dec. 1, 2023 -- A new study of identical twins has provided fresh evidence that a vegan diet can vastly improve a person’s heart health.Twins assigned a vegan diet for two months had significant improvements in cholesterol, insulin and.

105
105
article thumbnail

Revolutionizing the clinical trial patient experience with IQVIA

Fierce BioTech

What if clinical trial sites could focus entirely on research? | IQVIA’s new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors.

article thumbnail

New technology optimises mesenchymal stem cell extraction

Drug Target Review

A groundbreaking new technology that can extract mesenchymal stem cells (MSCs) directly from pure bone barrow, known as bone marrow aspirate (BMA) without dilution has been developed by researchers from the Critical Analytics for Manufacturing Personalised-Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART).

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

European regulators want to know more about the risks of GLP-1 drugs

BioPharma Drive: Drug Pricing

The EMA's safety committee has more questions for makers of the in-demand therapies as it reviews whether the drugs are linked to the risk of suicidal thoughts.

article thumbnail

Help for the Holidays: Preventing Fatigue, Violence, and Stress in Retail

NIOSH Science Blog: Drugs

The holidays can be the most stressful time of the year—especially for retail workers who often work long hours and irregular shifts. These workers might also deal with crowds, violence, and robberies. This blog highlights the risk of fatigue, violence, and stress for workers in retail stores and provides strategies for making retail work environments and workers safer and healthier.

104
104
article thumbnail

Your Personality Might Help Shield You From Dementia

Drugs.com

FRIDAY, Dec. 1, 2023 -- Got a naturally sunny disposition? It might protect you from dementia as the years advance, new research shows.

Research 116
article thumbnail

Cannabinoids Unleashed: Innovative Treatments in Medicine and Cosmetics

biobide

Cannabis derivatives In 2022 the global legal cannabis market was valued at USD 22.1 billion. This is forecasted to grow rapidly, with a growth rate of 25.5% by 2030. A Key contributing factor to this significant growth prediction is the accelerating legalization of cannabis products and the growing acceptance of its use in the medical field and consumer goods.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Couch Potatoes, 'Squatting Breaks' Could Keep Your Mind Sharp

Drugs.com

FRIDAY, Dec. 1, 2023 -- Doing some squats during commercial breaks or between YouTube videos can help couch potatoes keep their minds sharp, a new study suggests.Young volunteers who did short sets of squat exercises every now and then while.

98
article thumbnail

2023 CDD Holiday Poem (with ChatGPT)

Collaborative Drug

Dear CDD community: As we’ve been publishing annual CDD holiday poems for years, there was sufficient content as a “training set” covering the meaning and voice for ChatGPT to capture the spirit. Our new deep learning algorithm securely identifies structures and public structures similar to your own private molecules.

96
article thumbnail

Baseball Puts Kids' Elbows at Risk, Study Shows

Drugs.com

FRIDAY, DEC. 1, 2023 (Healthday News) -- Millions of American kids and teens love to play the game of baseball, but the sport can leave many with elbow pain and injuries, new research finds.“When we look at the forces that baseball players, even.

article thumbnail

Research shows human behavior guided by fast changes in dopamine levels

SCIENMAG: Medicine & Health

What happens in the human brain when we learn from positive and negative experiences? To help answer that question and better understand decision-making and human behavior, scientists are studying dopamine. Credit: Wake Forest University School of Medicine What happens in the human brain when we learn from positive and negative experiences?

article thumbnail

Respiratory Illnesses in China Not Caused by New Virus, CDC Director Testifies

Drugs.com

FRIDAY, Dec. 1, 2023 (Healthday News) -- In testimony provided Thursday to members of Congress, the head of the U.S. Centers for Disease Control and Prevention said that a surge in respiratory illnesses in China is not being fueled by a new.

article thumbnail

'Bone biographies' reveal lives of medieval England's common people -- and illuminate early benefits system

Science Daily: Pharmacology News

Researchers give medieval Cambridge residents the 'Richard III treatment' to reveal hard-knock lives of those in the city during its famous university's early years. Study of over 400 remains from a hospital cemetery shows spectrum of medieval poverty, and suggests that some of Cambridge University's earliest scholars ended up in penury.

article thumbnail

Persistent Inflammation Could Drive Brain Issues in Former Football Players

Drugs.com

FRIDAY, Dec. 1, 2023 -- The repeat head injuries suffered by football players, boxers and other athletes appear to affect brain health long after players have given up their sport.New research from Johns Hopkins University in Baltimore could.

article thumbnail

Scientists navigate uncharted waters in fish immunology research

SCIENMAG: Medicine & Health

Upon infection or immunization, all jawed vertebrate species generate proteins called antibodies that bind and neutralize pathogens. Strong and long-lasting antibody responses in warm-blooded species such as mammals are produced in secondary lymphoid microstructures (SLMs) among which germinal centers (GCs) are the centerpiece.

article thumbnail

As Salmonella Outbreak Widens, Avoid Cantaloupes if Brand Is Unknown, CDC Warns

Drugs.com

FRIDAY, Dec. 1, 2023 (Healthday News) -- Shoppers should steer clear of any pre-cut cantaloupe if the brand is unknown, as a salmonella outbreak linked to the fruit continues to widen, U.S. health officials warned Thursday.Eighteen more illnesses.

96
article thumbnail

A new possible explanation for the Hubble tension

Science Daily: Pharmacology News

The universe is expanding. How fast it does so is described by the so-called Hubble-Lemaitre constant. But there is a dispute about how big this constant actually is: Different measurement methods provide contradictory values. This so-called 'Hubble tension' poses a puzzle for cosmologists. Researchers are now proposing a new solution: Using an alternative theory of gravity, the discrepancy in the measured values can be easily explained -- the Hubble tension disappears.

article thumbnail

Pfizer plans for oral obesity drug hit new trial setback

BioPharma Drive: Drug Pricing

The company won’t continue development of a twice-daily dose of its experimental weight loss medicine danuglipron after study data showed high rates of side effects.

Trials 70
article thumbnail

Meteorites likely source of nitrogen for early Earth

Science Daily: Pharmacology News

Micrometeorites originating from icy celestial bodies in the outer Solar System may be responsible for transporting nitrogen to the near-Earth region in the early days of our solar system.

73
article thumbnail

Treatment Used on Donated Hearts May Be Useless, Even Harmful: Study

Drugs.com

FRIDAY, Dec. 1, 2023 -- A technique doctors use to preserve donated organs is actually doing no good, and might even be harming the organs, a new study reports.Physicians routinely dose deceased organ donors with thyroid hormones, in a bid to.

Doctors 64
article thumbnail

Ghostlike dusty galaxy reappears in James Webb Space Telescope image

Science Daily: Pharmacology News

Astronomers studying images from the James Webb Space Telescope have identified an object as a 'dusty star-forming galaxy' from nearly 1 billion years after the Big Bang. They have also discovered more than a dozen additional candidates, suggesting these galaxies might be three to 10 times as common as expected. If that conclusion is confirmed, it suggests the early universe was much dustier than previously thought.

65
article thumbnail

Talking cancer immunotherapy with Cell Signaling Technology

Fierce BioTech

Immunotherapy is a treatment which, if it triggers a positive response, can have a miraculous effect on the body’s ability to fight cancer. | CST fellow Amrik Singh outlines some of the key progress being made around CAR-T therapy and the impact that this highly specialized technique can have on cancer patients, even those who have been previously unresponsive to other forms of treatment.

article thumbnail

New patent for Glaxosmithkline drug ANORO ELLIPTA

Drug Patent Watch

Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fourteen patents… The post New patent for Glaxosmithkline drug ANORO ELLIPTA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

In a Time of Uncertainty for Clinical Researchers, Reliable Partners are Vital

Crucial Data Solutions

The clinical research industry is currently dealing with a great deal of uncertainty, with various solutions providers announcing layoffs often. The post In a Time of Uncertainty for Clinical Researchers, Reliable Partners are Vital appeared first on Crucial Data Solutions.

article thumbnail

New patent for Glaxosmithkline drug TRELEGY ELLIPTA

Drug Patent Watch

Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fourteen patents… The post New patent for Glaxosmithkline drug TRELEGY ELLIPTA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

What We Expect the FDA to do in December 2023

Agency IQ

In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods and more. The goal: To allow regulatory professionals to better anticipate and prepare for upcoming events and catalysts. Fill out the form to read the full article.

FDA 59
article thumbnail

New patent for Glaxo Grp drug BREO ELLIPTA

Drug Patent Watch

Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are… The post New patent for Glaxo Grp drug BREO ELLIPTA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59